OTL38: Clinical Trials

3 trials of OTL38, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Terminated 1, Withdrawn 1

Follow OTL38: new trials by email Literature Review of OTL38 trials Research Report on OTL38

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
OTL38, intraoperative imaging camera system - Ovarian Cancer
Phase 1WithdrawnAbramson Cancer Center at Penn Medicine2022-05-282022-06-27
Intraoperative Imaging of Pituitary Adenomas by OTL
OTL38 - Neoplasms, Pituitary Neoplasms
Phase 1TerminatedUniversity of Pennsylvania332015-10-012019-08-06
Intraoperative Imaging of Pulmonary Nodules by OTL38
OTL38 - Neoplasms
Phase 1CompletedUniversity of Pennsylvania2622015-05-012022-06-28

Conditions studied

Neoplasms (2)  ·  Ovarian Neoplasms (1)  ·  Pituitary Neoplasms (1)

Sponsors

University of Pennsylvania (2)  ·  Abramson Cancer Center at Penn Medicine (1)

Countries

United States (3)

Top investigators

Sunil Singhal (1)  ·  Sunil Singhal, MD (1)